Edwards Lifesciences Corporation · NYSE:EW
Lippis Daniel J. sold 619 Edwards Lifesciences Corporation shares (Form 4)
Traded Jun 30, 2026 · Filed Jun 30, 2026
On Jun 30, 2026, Lippis Daniel J. (CVP, TAVR) sold 619 Edwards Lifesciences Corporation shares at US$91.40 for US$56,577 under a trading plan, leaving 40,411 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 619 shares
- Price
- US$91.40
- Value
- US$56,577
- Holding after
- 40,411 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CVP, TAVR
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 619 | US$72.68 | 41,030 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 619 | US$91.40 | 40,411 | Direct |
Source
Related
- Edwards Lifesciences Corporation
- Lippis Daniel J.
- Edwards Lifesciences Corporation shareholders
- Form 4 · Lippis Daniel J. · Oct 8, 2026
- Form 4 · Lippis Daniel J. · Sep 11, 2026
- Form 4 · Lippis Daniel J. · Aug 11, 2026
- Form 4 · Lippis Daniel J. · Jul 10, 2026
- Form 4 · Lippis Daniel J. · Jul 7, 2026
- Form 4 · Markowitz Wayne · Sep 14, 2026
- Form 4 · Dahl Andrew M. · Sep 14, 2026
- Form 4 · Chopra Daveen · Sep 11, 2026
- Form 4 · Dahl Andrew M. · Aug 31, 2026
- Form 4 · Bruls Annette · Aug 28, 2026